¼¼°èÀÇ ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå º¸°í¼­(2025³â)
Interventional Lung Solutions Global Market Report 2025
»óǰÄÚµå : 1760572
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,312,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,124,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,936,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â°£ °­ÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µÀÇ È®»ê, °³ÀÎÈ­ ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡, ·Îº¿ º¸Á¶ ¼ö¼úÀÇ Àα⠻ó½Â, ÃÖ¼Ò Ä§½ÀÀû ÀýÂ÷ÀÇ È®»ê, Á¤¹Ð ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡ µî¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÷´Ü Æó¾Ï Ä¡·á¹ý °³¹ß, ±â°üÁö ³»½Ã°æ ½Ã½ºÅÛ¿¡ Àΰø Áö´É ÅëÇÕ, ÁßÀçÀû ÆóÇÐ ¹× Á¾¾ç Ä¡·áÀÇ ÅëÇÕ, Æó Áúȯ °ü¸®¸¦ À§ÇÑ µðÁöÅÐ Ç÷§Æû ÅëÇÕ, Æó Àç»ý Ä¡·áÀÇ Çõ½Å µîÀÌ ÀÖ½À´Ï´Ù.

È£Èí±â ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÇâÈÄ ¸î ³â µ¿¾È ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀåÀÇ È®ÀåÀÌ Å©°Ô ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. È£Èí±â ÁúȯÀº Æó¿Í ±âµµ¿¡ ¿µÇâÀ» ¹ÌÃÄ È£ÈíÀ» ¹æÇØÇϰí Á¤»óÀûÀΠȣÈí ±â´ÉÀ» ¹æÇØÇÏ´Â ´Ù¾çÇÑ ÀÇ·áÀû »óŸ¦ Æ÷ÇÔÇÕ´Ï´Ù. È£Èí±â ÁúȯÀÇ Áõ°¡ ´Â ÁÖ·Î ´ë±â ¿À¿° ¼öÁØ Áõ°¡·Î ÀÎÇØ À¯ÇØÇÑ °ø±â Áß ÀÔÀÚ ¹× Àڱع°Áú¿¡ Àå±â°£ ³ëÃâµÇ´Â °ÍÀÌ ÁÖ¿ä ¿øÀÎÀ¸·Î Áö¸ñµË´Ï´Ù. Æó ÁßÀçÀû ¼Ö·ç¼ÇÀº ¸¸¼º Æó Áúȯ ȯÀÚÀÇ Æó ±â´ÉÀ» °³¼±Çϰí Áõ»óÀ» ¿ÏÈ­ÇÏ´Â ÃÖ¼Ò Ä§½ÀÀû ÀýÂ÷¸¦ Á¦°øÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ÁúȯÀ» °ü¸®ÇÏ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 11¿ù, ¹Ì±¹ Á¤ºÎ ±â°üÀÎ Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ(CDC)´Â 2022³â ¹Ì±¹¿¡¼­ ¾à 8,331°ÇÀÇ °áÇÙ »ç·Ê°¡ º¸°íµÇ¾î Àü³âµµ¿¡ ºñÇØ 5.9% Áõ°¡Çß´Ù°í ¹àÇû½À´Ï´Ù. È£Èí±â ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϸ鼭 ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀåÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

ÁßÀçÀû Æó ¼Ö·ç¼Ç ½ÃÀåÀÇ ÁÖ¿ä ¾÷üµéÀº Æó¾Ï Áø´ÜÀÇ Á¤È®¼ºÀ» ³ôÀ̰í, ÃÖ¼Ò Ä§½ÀÀû ½Ã¼úÀ» °¡´ÉÇÏ°Ô Çϸç, ÷´Ü ³»ºñ°ÔÀÌ¼Ç ¹× »ý°Ë ±â´ÉÀ» ÅëÇØ ȯÀÚÀÇ Ä¡·á °á°ú¸¦ °³¼±Çϱâ À§ÇØ Ion Endoluminal System°ú °°Àº Ãֽűâ¼úÀÇ °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. Ion Endoluminal SystemÀº ÃÖ¼Ò Ä§½ÀÀû Æó ½Ã¼úÀ» À§ÇØ ¼³°èµÈ ·Îº¿ º¸Á¶ Ç÷§ÆûÀ¸·Î, À۰ųª Á¢±ÙÀÌ ¾î·Á¿î Æó °áÀý¿¡ Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï Á¤È®ÇÑ ±âµµ ³»ºñ°ÔÀ̼ÇÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 4¿ù ¹Ì±¹ ±â¹Ý ºñ¿µ¸® ±â°üÀÎ H. Lee Moffitt ¾Ï ¼¾ÅÍ ¹× ¿¬±¸¼Ò Àç´Ü(H. Lee Moffitt Cancer Center and Research Institute Foundation Inc.)Àº °í±Þ ±¤¼¶À¯ ±â¼ú°ú ÃÖ¼Ò Ä§½ÀÀû Ä«Å×ÅÍ ½Ã½ºÅÛÀ» °áÇÕÇÑ »õ·Î¿î Ion Robotic Bronchoscopy Ç÷§ÆûÀ» Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ±â¼úÀº ±¤¼¶À¯¿Í ½ÃÀå¿¡¼­ °¡Àå ÀÛÀº Ä«Å×Å͸¦ Ȱ¿ëÇØ ÆóÀÇ ¸ðµç ºÎÀ§¿¡ Á¢±ÙÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº 180¡Æ ȸÀüÀÌ °¡´ÉÇÑ ÃʹÚÇü, ±âµ¿¼ºÀÌ ¶Ù¾î³­ Ä«Å×ÅÍ, ÅëÇÕµÈ ½Ç½Ã°£ ¿µ»ó, Çü»ó °¨Áö ±â¼úÀ» Ư¡À¸·Î Çϸç, Á¢±ÙÀÌ ¾î·Á¿î ¸»ÃÊ Æó °áÀýÀÇ Á¤¹ÐÇÑ Å½»ö ¹× »ý°ËÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº Á¶Á÷ »ùÇøµ¿¡ Àü·Ê ¾ø´Â ¾ÈÁ¤¼º°ú Á¤È®¼ºÀ» Á¦°øÇÏ¿© Àǻ簡 18°³ Æó ºÎÀ§ ¸ðµÎ¿¡ Á¢±ÙÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á, ÃÊ±â Æó¾ÏÀÇ ¹ß°ß·üÀ» Çâ»ó½Ãŵ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª 19 ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°, ±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Interventional lung solutions refer to minimally invasive procedures and technologies designed to diagnose and treat lung conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, and emphysema. These solutions typically include interventions such as bronchoscopy, endobronchial valves, and image-guided therapies, all aimed at improving lung function and enhancing patient outcomes.

The main types of interventional lung solutions include bronchoscopes, endobronchial ultrasound needles, pleuroscopes, airway stents, and other related devices. Bronchoscopes are medical instruments used to visualize and examine the airways and lungs, typically inserted through the nose or mouth to diagnose and treat respiratory conditions. Technologies associated with bronchoscopes include robotic surgery, laser therapy, and electromagnetic navigation bronchoscopy. The procedures involved include bronchoscopy, thoracoscopy, pleuroscopy, and others. These solutions are applied in various medical fields such as lung cancer treatment, COPD management, and sleep apnea treatment, and are used by a variety of end-users, including hospitals, ambulatory surgical centers, specialty clinics, and other healthcare settings.

The interventional lung solutions market research report is one of a series of new reports from The Business Research Company that provides interventional lung solutions market statistics, including the interventional lung solutions industry's global market size, regional shares, competitors with the interventional lung solutions market share, detailed interventional lung solutions market segments, market trends and opportunities, and any further data you may need to thrive in the interventional lung solutions market. This interventional lung solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The interventional lung solutions market size has grown strongly in recent years. It will grow from $2.30 billion in 2024 to $2.49 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to the increasing prevalence of respiratory diseases, the growing number of smokers worldwide, rising air pollution levels, increasing healthcare awareness, and the growing number of lung cancer cases.

The interventional lung solutions market size is expected to see strong growth in the next few years. It will grow to $3.43 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to the growing adoption of telemedicine and remote monitoring, an increasing focus on personalized medicine, the rising popularity of robotic-assisted surgery, the growing adoption of minimally invasive procedures, and an increasing focus on precision medicine. Major trends expected during this period include the development of advanced lung cancer interventions, the integration of artificial intelligence in bronchoscopy systems, the merging of interventional pulmonology with oncology treatments, the integration of digital platforms for lung disease management, and innovations in lung regeneration therapies.

The growing prevalence of respiratory diseases is expected to significantly drive the expansion of the interventional lung solutions market in the coming years. Respiratory diseases encompass a range of medical conditions that affect the lungs and airways, impairing breathing and disrupting normal respiratory function. The increase in respiratory diseases is largely attributed to rising levels of air pollution, which contribute to prolonged exposure to harmful airborne particles and irritants. Interventional lung solutions assist in managing these diseases by providing minimally invasive procedures that improve lung function and alleviate symptoms in patients with chronic pulmonary conditions. For example, in November 2023, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported approximately 8,331 tuberculosis cases in the United States in 2022, marking a 5.9% increase from the previous year. This growing prevalence of respiratory diseases is driving the growth of the interventional lung solutions market.

Key players in the interventional lung solutions market are focusing on the development of cutting-edge technologies, such as the Ion Endoluminal System, to enhance the accuracy of lung cancer diagnostics, enable minimally invasive procedures, and improve patient outcomes through advanced navigation and biopsy capabilities. The Ion Endoluminal System is a robotic-assisted platform designed for minimally invasive lung procedures, enabling precise airway navigation to access small or difficult-to-reach lung nodules. For example, in April 2024, the H. Lee Moffitt Cancer Center and Research Institute Foundation Inc., a US-based non-profit organization, launched a new Ion Robotic Bronchoscopy platform to enhance their interventional pulmonology program with advanced fiber-optic technology and a minimally invasive catheter system. This technology employs fiber optics and the smallest catheter available on the market to access all areas of the lungs. It features an ultra-thin, highly maneuverable catheter with 180° articulation, integrated real-time vision, and shape-sensing technology, enabling precise navigation and biopsy of peripheral lung nodules that are difficult to reach. This system offers unprecedented stability and accuracy for tissue sampling, enabling physicians to reach all 18 lung segments, thus improving the detection of early-stage lung cancer.

In February 2025, Stryker Corporation, a US-based medical device company, acquired Inari Medical Inc. for an undisclosed amount. This acquisition is aimed at strengthening Stryker's interventional endovascular portfolio by adding innovative thrombolytic-free solutions for treating venous thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis. Inari Medical Inc., based in the US, specializes in providing interventional solutions for pulmonary conditions, with a particular focus on treating pulmonary embolism (PE).

Major players in the interventional lung solutions market are Johnson and Johnson, Siemens AG, Medtronic plc, FUJIFILM Holdings Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Smiths Medical Inc., Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., Vygon SA, AngioDynamics Inc., Vapotherm Inc., Pulmonx Corporation, Broncus Medical Inc., Thirona B.V., Body Vision Medical Ltd., The Lung Docs Inc., EndoMed Systems GmbH.

North America was the largest region in the interventional lung solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interventional lung solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the interventional lung solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The interventional lung solutions market consists of revenues earned by entities by providing services such as endobronchial valve placement, navigational bronchoscopy, lung volume reduction, and airway stenting. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional lung solutions market also consists of sales of products including bronchial thermoplasty devices, cryotherapy devices, bronchial stents, and biopsy forceps. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Lung Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional lung solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for interventional lung solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The interventional lung solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Interventional Lung Solutions Market Characteristics

3. Interventional Lung Solutions Market Trends And Strategies

4. Interventional Lung Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Interventional Lung Solutions Growth Analysis And Strategic Analysis Framework

6. Interventional Lung Solutions Market Segmentation

7. Interventional Lung Solutions Market Regional And Country Analysis

8. Asia-Pacific Interventional Lung Solutions Market

9. China Interventional Lung Solutions Market

10. India Interventional Lung Solutions Market

11. Japan Interventional Lung Solutions Market

12. Australia Interventional Lung Solutions Market

13. Indonesia Interventional Lung Solutions Market

14. South Korea Interventional Lung Solutions Market

15. Western Europe Interventional Lung Solutions Market

16. UK Interventional Lung Solutions Market

17. Germany Interventional Lung Solutions Market

18. France Interventional Lung Solutions Market

19. Italy Interventional Lung Solutions Market

20. Spain Interventional Lung Solutions Market

21. Eastern Europe Interventional Lung Solutions Market

22. Russia Interventional Lung Solutions Market

23. North America Interventional Lung Solutions Market

24. USA Interventional Lung Solutions Market

25. Canada Interventional Lung Solutions Market

26. South America Interventional Lung Solutions Market

27. Brazil Interventional Lung Solutions Market

28. Middle East Interventional Lung Solutions Market

29. Africa Interventional Lung Solutions Market

30. Interventional Lung Solutions Market Competitive Landscape And Company Profiles

31. Interventional Lung Solutions Market Other Major And Innovative Companies

32. Global Interventional Lung Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interventional Lung Solutions Market

34. Recent Developments In The Interventional Lung Solutions Market

35. Interventional Lung Solutions Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â